Project Details
Description
Coronaviruses (CoV) that infect humans are RNA viruses that have neurotropic characteristics and can be linked to serious damage to the nervous system (NS), with Beta CoV SARS-CoV-2 being of concern, which given its current global reach, In the future it could be linked to a greater proportion of neurological disorders.
The development of vaccines against SARS-COV2 took record time to deal with the ongoing pandemic and this has produced uncertainty about their use and the appearance of neurological adverse reactions.
The SARS-CoV-2 Spike protein (SP) was used as a formula to produce neutralizing antibodies and stimulate innate immunity; However, it is plausible that cross reactions may occur considering the alterations in the nervous system (SN) due to COVID-19.
The development of vaccines against SARS-COV2 took record time to deal with the ongoing pandemic and this has produced uncertainty about their use and the appearance of neurological adverse reactions.
The SARS-CoV-2 Spike protein (SP) was used as a formula to produce neutralizing antibodies and stimulate innate immunity; However, it is plausible that cross reactions may occur considering the alterations in the nervous system (SN) due to COVID-19.
Commitments / Obligations
Article for publication 01/01/2022 06/30/2022
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/21 → 6/30/22 |
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
Main Funding Source
- Installed Capacity (Academic Unit)
Location
- Bogotá D.C.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.